News Update on Stem Cells December 2020

Dr Rademaker- 50_pp

Stem cell-derived extracellular vesicles ease brain bleeding in newborn rats (Dec. 15, 2020)

For many premature babies there are extreme risks posed with being birthed underdeveloped, among these is intraventricular hemorrhage, which is bleeding in brain cavities containing cerebrospinal fluid. this often leads to complications resulting in the development of seizures, cerebral palsy, developmental defects, and a much higher mortality rate. There are currently no successful treatments for neonatal intraventricular hemorrhages (IVH). However, a recent study has shown that, in rats, treatment with extracellular vesicles from mesenchymal stem cells can lessen the damage from IVH and improve post-incident functionality and outcomes. This is believed to be because MSCs secrete a protein-coding gene called BDNF that, when introduced to the ventricular environment, alters the physiology in such a way as to minimize damage. BDNF is a neurotropic growth factor.

https://stemcellsportal.com/press-releases/stem-cell-derived-extracellular-vesicles-ease-brain-bleeding-newborn-rats?utm_source=iContact&utm_medium=email&utm_campaign=rmw&utm_content=RMW+December+22

 

Enhanced Scaffolds and Stem Cells Combine to Promote Bone Repair (Dec. 14, 2020)

Stem cells, scaffolds, and growth factors, when used in tandem, have been shown to repair bone damage. The most effective construct to date is direct injection of an adenovirus vector (rAAV) encoding BMP-2 along with mesenchymal stem cells. These demonstrate compatibility with bone-scaffolds and the slow release of newly encoded BNP prolongs the effects of MSCs in terms of osteogenic activity.

https://stemcellsportal.com/article-scans/enhanced-scaffolds-and-stem-cells-combine-promote-bone-repair?utm_source=iContact&utm_medium=email&utm_campaign=rmw&utm_content=RMW+December+22

 

New method to boost supply of life-saving stem cells (Dec. 18, 2020)

The authors of this study used an algorithm called VIPER to assess the human genome, looking for proteins capable of reprogramming blood-stem cells. Their aim was to force cells to acquire characteristics of hematopoietic stem cells. One protein they uncovered was BAZ2B, which was able to reprogram blood stem cells by rearranging their chromatin, opening up regions in the genome that were previously inaccessible, boosting their population numbers.

https://stemcellsportal.com/news/new-method-boost-supply-life-saving-stem-cells?utm_source=iContact&utm_medium=email&utm_campaign=rmw&utm_content=RMW+December+22

 

CIRM-funded study discovers potential therapy for one of the leading causes of heart disease (Dec. 16, 2020)

Heart disease is the leading cause of death for most demographic groups. Of the potential diseases in the heart, the third most prevalent is calcific aortic disease, which is when calcium starts to accumulate in the heart valves and vessels. This defect will cause them to harden dramatically, sometimes even becoming as hard as bone. This has led scientists to discover the cause most frequently being the NOTCH1 mutation, once corrected this has the potential to reverse calcification.

https://blog.cirm.ca.gov/2020/12/16/cirm-funded-study-discovers-potential-therapy-for-one-of-the-leading-causes-of-heart-disease/

https://gladstone.org/news/potential-therapy-one-leading-causes-heart-disease

 

First patient enrolled in stem cell therapy trial for traumatic injury (Dec. 21, 2020)

At the University of Texas health science center. To evaluate the safety and efficacy of MultiStem in the treatment of hemorrhage following traumatic injury. MultiStem is a clinical product is developed from a special class of stem cells: Multipotent Adult Progenitor Cells.

https://www.newswise.com/articles/first-patient-enrolled-in-stem-cell-therapy-trial-for-traumatic-injury

https://www.athersys.com/multistem-therapy/overview/default.aspx

 

Mesenchymal stromal cells in Human Immunodeficiency Virus‐infected patients with discordant immune response: Early results of a phase I/II clinical trial

Between 15-30% of HIV patients won’t increase T-cell counts even with viral suppression. When treated with viral suppressants and MSCs, these patients did not experience any significant increase in T-cell counts. For this reason the study was recommended for suspension.

https://stemcellsjournals.onlinelibrary.wiley.com/doi/10.1002/sctm.20-0213

 

 

Subscribe to
Dr. Rademaker's Newsletter

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Fuel
Master Class

Sign up to access Dr. Rademaker’s exclusive content for doctors.

Or schedule a call with Dr. Rademaker to learn more 

Share this post with your friends

Combatting “inflation” as healthcare practitioners

As standard market price-points’ changes are being passed off as inflation, many consumers are feeling the pinch on their bank accounts. In reality the truth is that there’s less inflation, it’s probably closer to what’s called “price gouging” as supply networks become over stressed due to supply-chain issues related to the COVID-19 pandemic1.

Read More →

Brain Enhancers – is this for you?

Brain Enhancement Strategies using Nootropics   I believe in this day and age we all deserve to get ideas orinsights as to what can help …

Read More →

Why Upregulate your Mitochondria with Methylene Blue

Methylene Blue Methylene blue, a compound used to treat a blood disorder called methemoglobinemia, has a reputation for being a cognitive and mitochondrial enhancer. Methylene …

Read More →

Leave a Comment

Your email address will not be published.

Scroll to Top